Psykiatrian yksikkö
Department of Psychiatry

Julkaisut 2009
Publications 2009

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Alaräisänen A et al. Suicide rate in schizophrenia in the Northern Finland 1966 birth cohort.
2 Fröjd S et al. Significance of family life events in middle adolescence: A survey on Finnish community adolescents.
3 Hintikka J et al. Are factors associated with suicidal ideation true risk factors? A 3-year prospective follow-up study in a general population.
4 Hintikka J et al. Unemployment and ill health: a connection through inflammation?
5 Hintikka J et al. Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men.
6 Hintikka J et al. Testosterone in male depression.
7 Hintikka J et al. Mental disorders in self-cutting adolescents.
8 Honkalampi K et al. The prevalence of alexithymia and its relationship with youth self-report problem scales among Finnish adolescents.
9 Isohanni M et al. Developmental pathways of schizophrenia: a system theoretical view and proposal of a system model.
10 Karvonen K et al. Suicides among older persons in Finland and time since hospitalization discharge.
11 Koskinen J et al. Prevalence of alcohol use disorders in schizophrenia - a systematic review and meta-analysis.
12 Laitinen K, Tacke U. Saako pään sekaisin itsehoitolääkkeillä?
13 Larsen JK et al. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
14 Laukkanen E et al. The prevalence of self-cutting and other self-harm among 13- to 18-year-old Finnish adolescents.
15 Lehto SM. Biological Findings in Major Depressive Disorder with Special Reference to the Atypical Features Subtype.
16 Lehto SM et al. Altered hemispheric balance of temporal cortex dopamine D2/3 receptor binding in major depressive disorder.
17 Lublin H et al. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: A 12-week open-label, multicentre clinical trial.
18 Miettunen J et al. Use of psychiatric and psychological instruments in Finland: schizophrenia and related psychoses.
19 Novick D et al. Translation of randomised controlled trial findings into clinical practice: Comparison of olanzapine and valproate in the EMBLEM study.
20 Oostervink F et al. Bipolar disorder in the elderly; different effects of age and of age of onset .
21 Ovaskainen Y et al. Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males.
22 Raij TT et al. Reality of auditory verbal hallucinations.
23 Ranta K et al. Associations between peer victimization, self-reported depression and social phobia among adolescents: The role of comorbidity.
24 Rissanen M-L et al. Descriptions of help by Finnish adolescents who self-mutilate.
25 Rissanen M-L et al. Helping adolescents who self-mutilate: parental descriptions .
26 Sinikallio S et al. Depressive burden in the preoperative and early recovery phase predicts poorer surgery outcome among lumbar spinal stenosis patients. A one-year prospective follow-up Study.
27 Sinikallio S et al. Life dissatisfaction is associated with a poorer surgery outcome and depression among lumbar spinal stenosis patients: a 2-year prospective study.
28 Suvisaari J et al. Mental disorders in young adulthood.
29 Tacke U, Laitinen K. Mikä ihmeen "seksihuume" MDPV?
30 Tacke U et al. A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine-naloxone combination.
31 Timonen MJ et al. Insulin resistance and schizophrenia: Results from the Northern Finland 1966 birth cohort.
32 Tolmunen T et al. Nuorten dissosiaation arvioiminen.
33 Tuisku V et al. Factors associated with deliberate self-harmbehaviour among depressed adolescent outpatients.
34 Tuppurainen H et al. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
35 Valtonen M et al. Leisure-time physical activity, cardiorespiratory fitness and feelings of hopelessness in men.
36 van Rossum I et al. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis.
37 Vanhala M et al. Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study.
38 Vieta E et al. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
39 Viinamäki H et al. Association of depressive symptoms and metabolic syndrome in men.
40 Viinamäki H et al. Depressio - patogeneesistä hoitoon.

Psykiatrian yksikkö Department of Psychiatry
Julkaisutietokanta 27.5.2010 Publications Data Base 27.5.2010